SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 135 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $116,281,451 | -20.2% | 3,086,845 | +4.2% | 0.01% | -28.6% |
| Q1 2024 | $145,771,133 | +52.5% | 2,961,624 | +13.1% | 0.01% | +40.0% |
| Q4 2023 | $95,617,225 | +60.8% | 2,619,650 | +1.9% | 0.01% | +66.7% |
| Q3 2023 | $59,446,052 | -28.2% | 2,571,196 | -18.5% | 0.00% | -25.0% |
| Q2 2023 | $82,738,547 | +14.3% | 3,155,551 | +12.2% | 0.00% | 0.0% |
| Q1 2023 | $72,362,116 | -63.0% | 2,811,271 | -62.6% | 0.00% | -33.3% |
| Q4 2022 | $195,370,942 | +106.0% | 7,511,378 | +126.0% | 0.01% | 0.0% |
| Q3 2022 | $94,835,000 | -1.0% | 3,324,062 | -14.5% | 0.01% | 0.0% |
| Q2 2022 | $95,753,000 | +6.3% | 3,889,249 | +143.7% | 0.01% | +50.0% |
| Q1 2022 | $90,072,000 | +10.2% | 1,595,890 | +21.0% | 0.00% | 0.0% |
| Q4 2021 | $81,758,000 | -3.1% | 1,319,111 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $84,338,000 | -5.4% | 1,329,418 | +22.9% | 0.00% | -20.0% |
| Q2 2021 | $89,161,000 | +12.3% | 1,081,921 | +0.2% | 0.01% | 0.0% |
| Q1 2021 | $79,424,000 | +1.6% | 1,079,568 | +0.1% | 0.01% | 0.0% |
| Q4 2020 | $78,173,000 | +105.8% | 1,077,952 | +35.3% | 0.01% | +66.7% |
| Q3 2020 | $37,985,000 | +140.8% | 796,842 | +112.2% | 0.00% | +200.0% |
| Q2 2020 | $15,773,000 | +236.9% | 375,536 | +116.5% | 0.00% | – |
| Q1 2020 | $4,682,000 | -16.3% | 173,419 | +19.4% | 0.00% | – |
| Q4 2019 | $5,591,000 | – | 145,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |